News Column

Leading Health Care Stock for Small-Cap Stars is Raptor Pharmaceutical Corp. (RPTP) for August 5

August 5, 2014

Equities Staff



Investing in small-cap health care companies can be tricky, with stocks that can soar or crash based on the results of a single clinical trial. However, equities.com's Small-Cap Stars, our proprietary list of small-cap companies with characteristics we've found to be most predictive of future success, isolates those companies that are best positioned to succeed.

Here are today's top performing health care Small-Cap Stars:

Raptor Pharmaceutical Corp. (RPTP)



Raptor Pharmaceutical Corp. gained 10.01% to $8.90. The gains came on a volume of 1,271,240 shares against an average daily volume of 548,888 shares. Raptor Pharmaceutical Corp. has had a trading range from $17.72 to $7.12 over the last year, it has a 50-day SMA of $9.84, and a 200-day SMA of $11.96.

Raptor Pharmaceutical Corp is a biopharmaceutical company focused on developing and commercializing life-altering therapeutics that treat debilitating and often fatal diseases.

Organovo (ONVO)



Organovo gained 7.77% to $7.77. The gains came on a volume of 1,370,600 shares against an average daily volume of 1,852,849 shares. Organovo has had a trading range from $13.65 to $4.61 over the last year, it has a 50-day SMA of $7.59, and a 200-day SMA of $8.37.

Organovo Holdings Inc is a development-stage company. It is engaged in developing and commercializing functional human tissues.

Ampio Pharmaceuticals Inc. (AMPE)



Ampio Pharmaceuticals Inc. gained 6.27% to $6.61. The gains came on a volume of 1,166,620 shares against an average daily volume of 678,919 shares. Ampio Pharmaceuticals Inc. has had a trading range from $10.86 to $5.06 over the last year, it has a 50-day SMA of $7.28, and a 200-day SMA of $7.45.

Ampio Pharmaceuticals, Inc. is a biopharmaceutical company, engaged in developing innovative, proprietary pharmaceutical drugs and diagnostic products to identify, treat and prevent human diseases including metabolic disorders, cancer etc.

Galectin Therapeutics Inc. (GALT)



Galectin Therapeutics Inc. gained 5.07% to $5.60. The gains came on a volume of 632,222 shares against an average daily volume of 993,963 shares. Galectin Therapeutics Inc. has had a trading range from $19.11 to $5.15 over the last year, it has a 50-day SMA of $12.80, and a 200-day SMA of $11.99.

Galectin Therapeutics, Inc. is a development-stage company engaged in drug research and development to create new therapies for fibrotic disease and cancer.

Chromadex Corp (CDXC)



Chromadex Corp gained 4.88% to $1.29. The gains came on a volume of 15,660 shares against an average daily volume of 64,573 shares. Chromadex Corp has had a trading range from $2.15 to $0.70 over the last year, it has a 50-day SMA of $1.38, and a 200-day SMA of $1.47.

ChromaDex Corp through its subsidiaries, supplies phytochemical referance standards to research an array of potential attributes & reference materials, related contract services, technical consulting & proprietary ingredients.

Equities.com's Health Care Small-Cap Stars - Helping You Build a Healthier Portfolio



No one can predict precisely which potential treatments will fly through their clinical trials and which will stumble along the way. At least, if someone can, they're undoubtedly spectacularly wealthy right now. But, while the science is clearly the most important factor for the success of a small-cap biotech company, it's not the only one.

Equities.com's Small-Cap Stars system uses a complicated statistical regression to determine which fundamental factors previous success stories had in common and then identifies those present health care small caps that share those traits. For health care companies, we found that a high enterprise value, a strong value line beta, and a high rate of reinvestment were among the most important qualities in predicting the potential success of a company.

All data provided by QuoteMedia and was accurate as of 4:30 pm ET.


For more stories covering the world of technology, please see HispanicBusiness' Tech Channel



Source: Equities.com


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters